Project would accelerate development of bird flu vaccine for humans
Drugmaker Sinergium Biotech, based in Argentina, will lead a project to accelerate the development of a human vaccine against the H5N1 avian flu virus, said the World Health Organization and the Medicines Patent Pool on Monday. The project is aimed at pharmaceutical companies in low- and middle-income nations and intended to bolster pandemic preparedness worldwide.
Moderna gets U.S. contract to develop bird flu vaccine
The government awarded a $176 million contract to Moderna to develop an mRNA-based vaccine to protect people from bird flu, said Health Secretary Xavier Becerra on Tuesday. Public health officials say the risk to the general population was low from the H5N1 avian flu virus, and there were no immediate plans to use the vaccine.